Literature DB >> 29989254

Canine urinary bladder transitional cell carcinoma tumor volume is dependent on imaging modality and measurement technique.

Andrew J Leffler1, Eric T Hostnik1, Emma E Warry1, Gregory G Habing2, Danelle M Auld3, Eric M Green1, Wm Tod Drost1.   

Abstract

Transitional cell carcinoma is the most common cancer of the canine urinary tract. The inconsistent appearance of transitional cell carcinoma in patients introduces error if applying mathematic models for extrapolating total tumor volume from linear measurements. Reliable techniques to assess tumor size are important for monitoring treatment response. A method comparison study was performed comparing four techniques for calculating tumor volume were compared: (1 and 2) contoured tracing of tumor margins using serial computed tomography (CT) images using pre-(1) and postintravenous (2) contrast medium studies, (3) longest three linear dimensions using CT, and (4) longest three linear dimensions on abdominal ultrasound. Volumes of the transitional cell carcinoma tumor calculated by CT tracing techniques were significantly smaller than volumes calculated with an ellipsoid mathematic model using the linear measurements (P < 0.01). Intravenous contrast medium did not significantly change the volumes calculated from tracing tumor margins on CT for observer B; however, volumes differed for observer A. The volumes extrapolated from linear measurements using CT and ultrasound did not differ significantly. The interobserver reliability was highest for the precontrast CT contoured technique and was lowest using the ultrasound linear technique. Tumor volumes differed significantly between techniques of contoured tracing of the tumor margins on serial CT images compared to calculation of tumor volume from linear dimensions. The calculated volume of a transitional cell carcinoma depends upon the technique used. Characterizing the response of urinary bladder transitional cell carcinoma tumor size to therapy differs based on the method and modality used.
© 2018 American College of Veterinary Radiology.

Entities:  

Keywords:  computed tomography; dog; measurement; response evaluation criteria in solid tumors; ultrasonography; urinary bladder cancer

Mesh:

Substances:

Year:  2018        PMID: 29989254      PMCID: PMC6218272          DOI: 10.1111/vru.12652

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  22 in total

1.  Statistical evaluation of agreement between two methods for measuring a quantitative variable.

Authors:  J Lee; D Koh; C N Ong
Journal:  Comput Biol Med       Date:  1989       Impact factor: 4.589

Review 2.  Management of transitional cell carcinoma of the urinary bladder in dogs: a review.

Authors:  Christopher M Fulkerson; Deborah W Knapp
Journal:  Vet J       Date:  2015-01-26       Impact factor: 2.688

3.  Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer.

Authors:  D W Knapp; N W Glickman; D B Denicola; P L Bonney; T L Lin; L T Glickman
Journal:  Urol Oncol       Date:  2000 Mar-Apr       Impact factor: 3.498

4.  Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.

Authors:  E J Arnold; M O Childress; L M Fourez; K M Tan; J C Stewart; P L Bonney; D W Knapp
Journal:  J Vet Intern Med       Date:  2011-09-13       Impact factor: 3.333

5.  Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document.

Authors:  S M Nguyen; D H Thamm; D M Vail; C A London
Journal:  Vet Comp Oncol       Date:  2013-03-28       Impact factor: 2.613

6.  Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden in pancreatic adenocarcinoma and hepatocellular carcinoma.

Authors:  Jessemae L Welsh; Kellie Bodeker; Elizabeth Fallon; Sundershan K Bhatia; John M Buatti; Joseph J Cullen
Journal:  Am J Surg       Date:  2012-08-14       Impact factor: 2.565

7.  Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study.

Authors:  Valerie J Poirier; Lisa J Forrest; William M Adams; David M Vail
Journal:  J Am Anim Hosp Assoc       Date:  2004 Mar-Apr       Impact factor: 1.023

8.  Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma.

Authors:  Diane R Schrempp; Michael O Childress; Jane C Stewart; Tiffany N Leach; Kean Ming Tan; Andrew H Abbo; Amalia E de Gortari; Patty L Bonney; Deborah W Knapp
Journal:  J Am Vet Med Assoc       Date:  2013-06-01       Impact factor: 1.936

9.  Ultrasonographic findings related to prognosis in canine transitional cell carcinoma.

Authors:  Kiwamu Hanazono; Shinya Fukumoto; Yoshifumi Endo; Hiroshi Ueno; Tsuyoshi Kadosawa; Tsuyoshi Uchide
Journal:  Vet Radiol Ultrasound       Date:  2013-07-26       Impact factor: 1.363

10.  TOLERABILITY AND TUMOR RESPONSE OF A NOVEL LOW-DOSE PALLIATIVE RADIATION THERAPY PROTOCOL IN DOGS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER AND URETHRA.

Authors:  Kevin Choy; Janean Fidel
Journal:  Vet Radiol Ultrasound       Date:  2016-02-03       Impact factor: 1.363

View more
  4 in total

1.  Presumptive malignant transformation of chronic polypoid cystitis into an apical transitional cell carcinoma without BRAF mutation in a young female dog.

Authors:  Emmanuelle Marie Butty; Shelley Hahn; Mary Anna Labato
Journal:  J Vet Intern Med       Date:  2021-03-19       Impact factor: 3.333

2.  Treatment of genitourinary carcinoma in dogs using nonsteroidal anti-inflammatory drugs, mitoxantrone, and radiation therapy: A retrospective study.

Authors:  Benoit Clerc-Renaud; Tracy L Gieger; Susan M LaRue; Michael W Nolan
Journal:  J Vet Intern Med       Date:  2021-02-26       Impact factor: 3.333

Review 3.  Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in Dogs.

Authors:  Jason Chibuk; Andi Flory; Kristina M Kruglyak; Nicole Leibman; Alexis Nahama; Nilesh Dharajiya; Dirk van den Boom; Taylor J Jensen; Jeffrey S Friedman; M Richard Shen; Francisco Clemente-Vicario; Ilya Chorny; John A Tynan; Katherine M Lytle; Lauren E Holtvoigt; Muhammed Murtaza; Luis A Diaz; Dana W Y Tsui; Daniel S Grosu
Journal:  Front Vet Sci       Date:  2021-03-23

4.  Quantitative analysis of the BRAF V595E mutation in plasma cell-free DNA from dogs with urothelial carcinoma.

Authors:  Michihito Tagawa; Naomi Tambo; Masaki Maezawa; Mizuki Tomihari; Ken-Ichi Watanabe; Hisashi Inokuma; Kazuro Miyahara
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.